Skip to main content
logo
SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
4.020
+0.070 (1.77%)
At close: Nov 24, 2025, 4:00 PM EST
3.940
-0.080 (-1.99%)
After-hours: Nov 24, 2025, 6:05 PM EST

SAB Biotherapeutics Revenue

SAB Biotherapeutics had revenue of $114.70K in the twelve months ending September 30, 2025, down -92.42% year-over-year. In the year 2024, SAB Biotherapeutics had annual revenue of $1.32M, down -40.94%.

Revenue (ttm)
$114.70K
Revenue Growth
-92.42%
P/S Ratio
1,668.55
Revenue / Employee
$1,821
Employees
63
Market Cap
191.38M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.32M-916.58K-40.94%
Dec 31, 20232.24M-21.67M-90.63%
Dec 31, 202223.90M-36.97M-60.73%
Dec 31, 202160.88M5.64M10.21%
Dec 31, 202055.24M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

SABS News

More News